Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY: TMO )

531.85 -0.79 (-0.15%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
Where Thermo Fisher Scientific Stands With Analysts
Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst rating... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021
Upgrades For Iridium Communications Inc (NASDAQ:IRD... 
Via Benzinga
Chinese Growth Level
The hot news today was a much weaker Chinese growth level this year, of 4.9% because of supply chain issues. 
Via Talk Markets
TMO Stock Forecast: The World Leader In Serving Science
TMO is a strong buy stock, it is a stable and powerful technology stock with good management and a strong financial position, which is reasonable for long-term holding. 
Via Talk Markets
3 Dividend Stocks That Hiked Their Payouts by More Than 10% This Year
And more rate hikes are likely in their future. 
Via The Motley Fool
Friday Market Coverage
New hiring again failed to rise in Sept., the 2nd month in a row which may be good news because it could delay the Fed tapering. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Semiconductor Shortage Hits Supply Chain For MedTech Industry
According to a study commissioned by AdvaMed, the global semiconductor chip shortage is causing delays, order cancellations, and other supply disruptions at MedTech companies.... 
Via Benzinga
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests. The agency has asked COVID-19... 
Via Benzinga
Exposures COVID-19 Product Safety
'Fast Money Halftime Report' Picks For September 23
On CNBC's "Fast Money Halftime Report," Karen Firestone said Thermo Fisher Scientific Inc. (NYSE: TMO) had a great analyst day. It raised guidance for 2022 and the... 
Via Benzinga
Expert Ratings For Thermo Fisher Scientific
Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst rating... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Piper Sandler boosted the price target for Adobe Inc. (NASDAQ: ADBE) from $600 to $670. Adobe shares fell 3.5% to $623.50 in pre-market trading. Keybanc reduced the price target... 
Via Benzinga
A Day Of Huge Market Moves
It was a day of huge market moves and several reporting companies. Trudeau won but did not get a parliamentary majority. 
Via Talk Markets
Pharma, Tech and Finance
Good news on some drugs was not enough to boost stock markets. 
Via Talk Markets
Analyst Ratings For Thermo Fisher Scientific
Within the last quarter, Thermo Fisher Scientific (NYSE:TMO) has observed the... 
Via Benzinga
10 Biggest Price Target Changes For Monday
Barclays boosted Upstart Holdings, Inc. (NASDAQ:UPST 
Via Benzinga
48 Biggest Movers From Friday
Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by... 
Via Benzinga
Why Thermo Fisher Shares Are Trading Higher Today
Thermo Fisher Scientific Inc (NYSE: TMO) is trading higher Friday after the company issued full-year 2022 financial guidance above analyst estimates. Thermo Fisher... 
Via Benzinga
Thermo Fisher Called For A Covid Testing Dive, And Soared — Here's Why
Thermo Fisher Scientific crushed guidance expectations for 2022 and beyond on Friday, and TMO stock surged to a fresh high. 
Via Investor's Business Daily
Investor React Positively To Thermo Fisher's Annual Guidance
Thermo Fisher Scientific Inc (NYSE: TMO) provided initial revenue and earnings guidance for 2022 while reiterating previously disclosed financial guidance for full... 
Via Benzinga
Takeda's Exkivity Scores FDA Nod As First Oral Therapy For Lung Cancer With EGFR Exon20 Insertion
The FDA has approved Takeda Pharmaceutical Co Ltd's (NYSE: TAK) Exkivity (mobocertinib) for non-small cell lung cancer (NSCLC) settings. The approval comes for... 
Via Benzinga
Exposures Product Safety
Post-Rosh Hashanah, Sell?
As the saying goes, sell Rosh Hashanah and buy Yom Kippur. Does it apply this year? 
Via Talk Markets
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
5 Largest US M&A Deals In Q2: Railways, Health Care, REITS And More
The second quarter started strong with four of the five largest deals announced in the month of April. 
Via Talk Markets
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
5 Largest US M&A Deals In Q2: Railways, Health Care, REITS And More
Global merger and acquisition activity topped $1 trillion in the second quarter of 2021, with the U.S alone topping $500 billion. This was the third quarter in a row that this... 
Via Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
Exposures COVID-19
Thermo Fisher Receives $192.5M Contract From US Govt For Pipette Tip Manufacturing
Thermo Fisher Scientific Inc (NYSE: TMO) has announced a $192.5 million contract award from the U.S. Department of Defense (DoD). The contract covers the domestic... 
Via Benzinga
FDA Clears Thermo Fisher's Companion Diagnostic Test For Bile Duct Cancer Drug
The FDA has granted pre-market approval to Thermo Fisher Scientific Inc's (NYSE: TMO) Oncomine Dx Target Test. The approval for the test comes as a... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures COVID-19
Stocks That Hit 52-Week Highs On Monday
Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG... 
Via Benzinga
< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS